Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs
Perceived Changes in Body Habitus and Body Image Among HIV+ Persons Currently Receiving or Recently Discontinuing Combination Antiretroviral Therapy
2 other identifiers
observational
60
1 country
4
Brief Summary
The purpose of this study is to learn how changes in body build affect the lives of people taking anti-HIV medications. By learning this, a set of questions can be created to help understand how changes in body build and image affect people living with HIV infection. A set of questions used to measure body image might be useful in future HIV studies. It may help doctors understand patient concerns about their body image and why some patients stop taking their anti-HIV medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2000
CompletedFirst Posted
Study publicly available on registry
August 31, 2001
CompletedSeptember 25, 2008
June 1, 2003
September 21, 2000
September 24, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Patients may be eligible for this study if they:
- Are 18 years or older.
- Are HIV-positive.
- Are experiencing at least 1 of the following symptoms associated with fat changes due to HIV: 1) increase in belt or waist size; 2) increase in size of back of neck; 3) increase in bra, shirt, or blouse size to fit increasing breast size; 4) fat increase in other areas of the body; 5) loss of facial fat; 6) loss of fat in arms or legs; 7) loss of fat in buttocks.
- Agree to protect the confidentiality of other focus group participants.
- Are able to speak and read English.
- Have taken 2 or more anti-HIV medications for a total of at least 6 months at any time before entering this study. Patients must have taken some anti-HIV treatment during the 6-month period before study entry. Patients who have stopped taking these medications in the 6 months before study entry may still be eligible.
- Are willing to talk about personal topics in a taped group interview.
- Are male and either gay or bisexual (if enrolling in the Ohio State University or University of California focus groups).
- Are either female or heterosexual male (if enrolling in the University of Pennsylvania or Johns Hopkins University focus groups).
You may not qualify if:
- Patients will not be eligible for this study if they:
- Have a mental disability that, in the opinion of the researcher, could interfere with study participation.
- Have already taken part in an A5089 focus group interview.
- Have diabetes or Cushing's disease or have had surgery that might otherwise explain changes in body fat.
- Have changes in diet or physical activity that might explain changes in body fat.
- Have been on glucocorticoid therapy for a long time.
- Are pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Univ of California, San Diego
San Diego, California, 92103, United States
Johns Hopkins Hosp
Baltimore, Maryland, 21287, United States
Ohio State Univ Hosp Clinic
Columbus, Ohio, 432101228, United States
Univ of Pennsylvania at Philadelphia
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Judith Neidig
- STUDY CHAIR
William Holmes
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
September 21, 2000
First Posted
August 31, 2001
Last Updated
September 25, 2008
Record last verified: 2003-06